Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 15 studies | 32% ± 15% | |
| peripheral blood | 15 studies | 32% ± 10% | |
| intestine | 9 studies | 29% ± 14% | |
| kidney | 8 studies | 29% ± 11% | |
| brain | 8 studies | 23% ± 6% | |
| eye | 7 studies | 23% ± 9% | |
| bone marrow | 5 studies | 27% ± 6% | |
| liver | 5 studies | 35% ± 21% | |
| lymph node | 5 studies | 35% ± 11% | |
| uterus | 4 studies | 34% ± 16% | |
| breast | 4 studies | 23% ± 4% | |
| pancreas | 3 studies | 37% ± 13% | |
| placenta | 3 studies | 40% ± 10% | |
| adrenal gland | 3 studies | 29% ± 12% | |
| prostate | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6676.49 | 1445 / 1445 | 100% | 118.82 | 183 / 183 |
| lung | 100% | 6973.32 | 578 / 578 | 100% | 151.63 | 1155 / 1155 |
| ovary | 100% | 7037.37 | 180 / 180 | 100% | 138.23 | 430 / 430 |
| pancreas | 100% | 5554.29 | 328 / 328 | 100% | 121.62 | 178 / 178 |
| prostate | 100% | 5699.05 | 245 / 245 | 100% | 163.05 | 502 / 502 |
| uterus | 100% | 6383.81 | 170 / 170 | 100% | 189.31 | 459 / 459 |
| breast | 100% | 6870.35 | 459 / 459 | 100% | 200.54 | 1117 / 1118 |
| intestine | 100% | 6318.22 | 966 / 966 | 100% | 180.15 | 526 / 527 |
| skin | 100% | 9449.32 | 1809 / 1809 | 100% | 204.22 | 471 / 472 |
| thymus | 100% | 5557.86 | 653 / 653 | 100% | 142.70 | 603 / 605 |
| stomach | 100% | 5741.20 | 359 / 359 | 100% | 154.40 | 285 / 286 |
| bladder | 100% | 7117.33 | 21 / 21 | 100% | 187.72 | 502 / 504 |
| adrenal gland | 100% | 10958.22 | 258 / 258 | 100% | 153.82 | 229 / 230 |
| kidney | 100% | 5791.70 | 89 / 89 | 99% | 121.41 | 895 / 901 |
| liver | 100% | 3850.69 | 225 / 226 | 100% | 90.19 | 404 / 406 |
| brain | 98% | 5062.69 | 2596 / 2642 | 100% | 113.29 | 705 / 705 |
| adipose | 100% | 7077.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 8368.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 174.44 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 300.25 | 29 / 29 |
| muscle | 100% | 7228.54 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7426.07 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 166.15 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 118.75 | 1 / 1 |
| heart | 96% | 5830.98 | 826 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 8418.71 | 859 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007339 | Biological process | binding of sperm to zona pellucida |
| GO_1904871 | Biological process | positive regulation of protein localization to Cajal body |
| GO_0061077 | Biological process | chaperone-mediated protein folding |
| GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
| GO_1904851 | Biological process | positive regulation of establishment of protein localization to telomere |
| GO_0006457 | Biological process | protein folding |
| GO_0050821 | Biological process | protein stabilization |
| GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005874 | Cellular component | microtubule |
| GO_0005832 | Cellular component | chaperonin-containing T-complex |
| GO_0002199 | Cellular component | zona pellucida receptor complex |
| GO_0005813 | Cellular component | centrosome |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0034774 | Cellular component | secretory granule lumen |
| GO_0045111 | Cellular component | intermediate filament cytoskeleton |
| GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
| GO_0005929 | Cellular component | cilium |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0044297 | Cellular component | cell body |
| GO_0044183 | Molecular function | protein folding chaperone |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0051082 | Molecular function | unfolded protein binding |
| GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
| GO_0005524 | Molecular function | ATP binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| Gene name | CCT8 |
| Protein name | T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15) T-complex protein 1 subunit theta (CCT-theta) Chaperonin containing TCP1 subunit 8 |
| Synonyms | KIAA0002 CCTQ hCG_1810843 C21orf112 |
| Description | FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis . The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance . As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia . The TRiC complex plays a role in the folding of actin and tubulin (Probable). . |
| Accessions | ENST00000286788.9 [P50990-1] ENST00000707892.1 [P50990-3] ENST00000626972.2 [P50990-2] H7C4C8 ENST00000707884.1 [P50990-1] ENST00000432178.5 ENST00000540844.5 [P50990-3] ENST00000707885.1 [P50990-2] ENST00000431234.1 P50990 H7C2U0 Q7Z759 |